| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bacterial Toxins | 60 | 2024 | 265 | 11.080 |
Why?
|
| Bacterial Proteins | 30 | 2024 | 474 | 6.040 |
Why?
|
| Bacillus anthracis | 30 | 2020 | 146 | 4.070 |
Why?
|
| Antigens, Bacterial | 29 | 2021 | 159 | 3.880 |
Why?
|
| Macrophages | 19 | 2018 | 273 | 2.590 |
Why?
|
| Clostridium Infections | 13 | 2024 | 66 | 2.170 |
Why?
|
| Gene Expression Regulation, Bacterial | 9 | 2024 | 152 | 1.740 |
Why?
|
| Anthrax | 14 | 2020 | 85 | 1.650 |
Why?
|
| Animals | 62 | 2024 | 9961 | 1.510 |
Why?
|
| Antibodies, Neutralizing | 11 | 2021 | 69 | 1.390 |
Why?
|
| Spores, Bacterial | 7 | 2022 | 45 | 1.370 |
Why?
|
| Virulence Factors | 7 | 2021 | 45 | 1.350 |
Why?
|
| Epitopes | 7 | 2020 | 171 | 1.330 |
Why?
|
| Mice | 43 | 2024 | 4407 | 1.260 |
Why?
|
| Enterotoxins | 4 | 2021 | 21 | 1.240 |
Why?
|
| CHO Cells | 16 | 2020 | 96 | 1.140 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 3 | 2018 | 26 | 1.090 |
Why?
|
| Glycogen Synthase Kinase 3 | 5 | 2011 | 31 | 1.060 |
Why?
|
| Leukocytes | 2 | 2018 | 67 | 1.040 |
Why?
|
| Repressor Proteins | 2 | 2019 | 114 | 1.020 |
Why?
|
| Cell Line | 18 | 2018 | 672 | 1.000 |
Why?
|
| Cytokines | 6 | 2018 | 438 | 0.930 |
Why?
|
| Virulence | 11 | 2021 | 144 | 0.920 |
Why?
|
| Cyclic AMP | 4 | 2018 | 80 | 0.910 |
Why?
|
| Immunoglobulin G | 14 | 2024 | 266 | 0.870 |
Why?
|
| Bacterial Vaccines | 2 | 2022 | 28 | 0.850 |
Why?
|
| Enterocolitis, Pseudomembranous | 3 | 2015 | 12 | 0.840 |
Why?
|
| Slipped Capital Femoral Epiphyses | 1 | 2022 | 1 | 0.840 |
Why?
|
| Femur Head Necrosis | 1 | 2022 | 2 | 0.840 |
Why?
|
| Cricetulus | 9 | 2020 | 56 | 0.840 |
Why?
|
| Embryo, Nonmammalian | 3 | 2007 | 25 | 0.800 |
Why?
|
| Clostridium | 6 | 2004 | 61 | 0.750 |
Why?
|
| Receptors, Peptide | 5 | 2012 | 20 | 0.750 |
Why?
|
| Peptide Fragments | 3 | 2017 | 197 | 0.710 |
Why?
|
| Humans | 39 | 2024 | 26828 | 0.700 |
Why?
|
| B-Lymphocytes | 7 | 2024 | 275 | 0.700 |
Why?
|
| Immunity, Innate | 3 | 2022 | 205 | 0.660 |
Why?
|
| Signal Transduction | 6 | 2020 | 1344 | 0.660 |
Why?
|
| Antibodies, Bacterial | 8 | 2021 | 100 | 0.660 |
Why?
|
| Natural Killer T-Cells | 5 | 2022 | 54 | 0.650 |
Why?
|
| Cricetinae | 12 | 2016 | 129 | 0.650 |
Why?
|
| HeLa Cells | 7 | 2023 | 206 | 0.640 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2018 | 25 | 0.630 |
Why?
|
| Clostridium sordellii | 2 | 2009 | 2 | 0.610 |
Why?
|
| Food Additives | 1 | 2018 | 2 | 0.600 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2017 | 6 | 0.590 |
Why?
|
| Anthrax Vaccines | 7 | 2020 | 34 | 0.590 |
Why?
|
| Amino Acid Sequence | 8 | 2024 | 674 | 0.560 |
Why?
|
| Mice, Inbred BALB C | 9 | 2013 | 264 | 0.510 |
Why?
|
| Peptidoglycan | 2 | 2013 | 47 | 0.510 |
Why?
|
| Zebrafish | 5 | 2010 | 93 | 0.510 |
Why?
|
| T-Lymphocytes, Cytotoxic | 4 | 1999 | 29 | 0.480 |
Why?
|
| Genes, Bacterial | 8 | 2008 | 106 | 0.480 |
Why?
|
| Antigenic Variation | 1 | 2013 | 3 | 0.440 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2013 | 6 | 0.440 |
Why?
|
| Receptor, Notch1 | 1 | 2013 | 25 | 0.430 |
Why?
|
| Mice, Inbred C57BL | 17 | 2024 | 1476 | 0.430 |
Why?
|
| Apoptosis | 3 | 2007 | 739 | 0.430 |
Why?
|
| Cytotoxins | 2 | 2006 | 51 | 0.430 |
Why?
|
| Mutation | 10 | 2021 | 817 | 0.410 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 623 | 0.410 |
Why?
|
| Immunization | 8 | 2022 | 118 | 0.410 |
Why?
|
| Protein Conformation | 3 | 2019 | 250 | 0.410 |
Why?
|
| Monocytes | 1 | 2013 | 132 | 0.400 |
Why?
|
| Hazardous Substances | 1 | 2011 | 6 | 0.390 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2011 | 13 | 0.370 |
Why?
|
| Immunosuppressive Agents | 2 | 2011 | 140 | 0.370 |
Why?
|
| Macrolides | 2 | 2001 | 18 | 0.370 |
Why?
|
| Shock, Septic | 2 | 2013 | 38 | 0.360 |
Why?
|
| Molecular Sequence Data | 8 | 2015 | 1036 | 0.350 |
Why?
|
| Multiprotein Complexes | 1 | 2011 | 50 | 0.350 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 93 | 0.350 |
Why?
|
| Cells, Cultured | 6 | 2013 | 970 | 0.340 |
Why?
|
| Phenotype | 4 | 2021 | 665 | 0.330 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2009 | 38 | 0.330 |
Why?
|
| Dendritic Cells | 1 | 2011 | 141 | 0.330 |
Why?
|
| Glycosylation | 4 | 2019 | 69 | 0.310 |
Why?
|
| Hydrogen-Ion Concentration | 6 | 2010 | 261 | 0.310 |
Why?
|
| Heart | 2 | 2007 | 219 | 0.310 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2020 | 34 | 0.300 |
Why?
|
| Cell Nucleus | 1 | 2008 | 135 | 0.300 |
Why?
|
| Phosphorylation | 4 | 2011 | 560 | 0.300 |
Why?
|
| Alanine | 1 | 2007 | 40 | 0.290 |
Why?
|
| Immunologic Memory | 4 | 2024 | 58 | 0.280 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 1998 | 45 | 0.280 |
Why?
|
| Caspases | 2 | 2007 | 43 | 0.280 |
Why?
|
| Galactosylceramides | 4 | 2021 | 31 | 0.260 |
Why?
|
| Adenylyl Cyclases | 1 | 2005 | 14 | 0.250 |
Why?
|
| RNA, Messenger | 4 | 2023 | 646 | 0.250 |
Why?
|
| Female | 21 | 2024 | 14463 | 0.240 |
Why?
|
| Germinal Center | 1 | 2024 | 20 | 0.230 |
Why?
|
| Cytosol | 2 | 2001 | 47 | 0.230 |
Why?
|
| Receptors, CXCR4 | 1 | 2024 | 27 | 0.230 |
Why?
|
| Antigens, CD1d | 4 | 2016 | 45 | 0.220 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2023 | 7 | 0.220 |
Why?
|
| Mutagenesis, Insertional | 3 | 2008 | 37 | 0.220 |
Why?
|
| Immunity, Humoral | 3 | 2020 | 46 | 0.210 |
Why?
|
| Neutralization Tests | 7 | 2020 | 32 | 0.210 |
Why?
|
| Vaccination | 3 | 2021 | 167 | 0.210 |
Why?
|
| Gene Expression | 4 | 2013 | 406 | 0.210 |
Why?
|
| Antibody Specificity | 3 | 2020 | 113 | 0.210 |
Why?
|
| Epiphyses | 1 | 2022 | 1 | 0.210 |
Why?
|
| Respiratory Tract Infections | 2 | 2013 | 35 | 0.210 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 3 | 2008 | 40 | 0.210 |
Why?
|
| Geologic Sediments | 3 | 2007 | 67 | 0.200 |
Why?
|
| Radiography | 1 | 2022 | 200 | 0.200 |
Why?
|
| Alum Compounds | 1 | 2022 | 6 | 0.200 |
Why?
|
| Quorum Sensing | 1 | 2021 | 5 | 0.200 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2021 | 13 | 0.190 |
Why?
|
| Ovalbumin | 2 | 1998 | 7 | 0.190 |
Why?
|
| Digestive System | 1 | 2021 | 16 | 0.190 |
Why?
|
| Receptors, Fc | 1 | 2021 | 30 | 0.190 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2018 | 73 | 0.180 |
Why?
|
| Membrane Proteins | 2 | 2023 | 465 | 0.180 |
Why?
|
| Peptides | 2 | 2021 | 280 | 0.180 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 72 | 0.180 |
Why?
|
| Civil Defense | 1 | 2020 | 2 | 0.180 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2021 | 64 | 0.180 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2018 | 130 | 0.180 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 44 | 0.180 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 324 | 0.180 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2020 | 9 | 0.170 |
Why?
|
| Antitoxins | 2 | 2021 | 13 | 0.170 |
Why?
|
| Movement | 1 | 2020 | 92 | 0.170 |
Why?
|
| Protein Binding | 3 | 2013 | 632 | 0.170 |
Why?
|
| Betacoronavirus | 1 | 2020 | 37 | 0.170 |
Why?
|
| Recombinant Proteins | 5 | 2011 | 408 | 0.170 |
Why?
|
| Protein Structure, Tertiary | 4 | 2015 | 283 | 0.170 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 47 | 0.170 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 51 | 0.170 |
Why?
|
| Biomedical Research | 1 | 2020 | 93 | 0.160 |
Why?
|
| Sequence Deletion | 1 | 2019 | 65 | 0.160 |
Why?
|
| Protein Domains | 1 | 2019 | 48 | 0.160 |
Why?
|
| Epitopes, B-Lymphocyte | 2 | 2009 | 24 | 0.160 |
Why?
|
| Plasma Cells | 1 | 2019 | 21 | 0.160 |
Why?
|
| Depsipeptides | 1 | 2018 | 5 | 0.160 |
Why?
|
| Pandemics | 1 | 2020 | 166 | 0.160 |
Why?
|
| Endopeptidase Clp | 1 | 2018 | 9 | 0.160 |
Why?
|
| RAW 264.7 Cells | 1 | 2018 | 21 | 0.160 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2019 | 30 | 0.160 |
Why?
|
| Immunomodulation | 1 | 2018 | 19 | 0.160 |
Why?
|
| Phagocytosis | 2 | 2010 | 78 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 5 | 2013 | 496 | 0.160 |
Why?
|
| Phylogeny | 1 | 2020 | 460 | 0.150 |
Why?
|
| Immunoconjugates | 1 | 1998 | 17 | 0.150 |
Why?
|
| Molecular Weight | 2 | 2011 | 118 | 0.150 |
Why?
|
| Amiloride | 1 | 2017 | 3 | 0.150 |
Why?
|
| Pinocytosis | 1 | 2017 | 17 | 0.150 |
Why?
|
| Host-Pathogen Interactions | 3 | 2019 | 89 | 0.140 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 152 | 0.140 |
Why?
|
| Blotting, Western | 2 | 2009 | 503 | 0.140 |
Why?
|
| Desulfovibrio desulfuricans | 2 | 2007 | 9 | 0.140 |
Why?
|
| Proteolysis | 2 | 2018 | 55 | 0.140 |
Why?
|
| Shewanella | 2 | 2006 | 9 | 0.130 |
Why?
|
| Cell Differentiation | 1 | 2019 | 395 | 0.130 |
Why?
|
| Interleukin-4 | 2 | 2016 | 23 | 0.130 |
Why?
|
| Cross Reactions | 2 | 2013 | 65 | 0.130 |
Why?
|
| Retrospective Studies | 1 | 2022 | 2433 | 0.130 |
Why?
|
| Epitope Mapping | 2 | 2013 | 38 | 0.130 |
Why?
|
| Cardiotoxicity | 1 | 2015 | 4 | 0.130 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2015 | 23 | 0.120 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 1393 | 0.120 |
Why?
|
| Adult | 7 | 2020 | 7383 | 0.120 |
Why?
|
| Lymphocyte Activation | 3 | 2022 | 204 | 0.120 |
Why?
|
| Transfection | 2 | 2008 | 313 | 0.120 |
Why?
|
| Caspase Inhibitors | 2 | 2006 | 8 | 0.120 |
Why?
|
| Sequence Alignment | 1 | 2015 | 110 | 0.120 |
Why?
|
| Flow Cytometry | 3 | 2010 | 282 | 0.120 |
Why?
|
| Middle Aged | 6 | 2020 | 6818 | 0.120 |
Why?
|
| Enzyme Activation | 2 | 2007 | 262 | 0.120 |
Why?
|
| DNA, Bacterial | 5 | 2007 | 301 | 0.120 |
Why?
|
| Base Sequence | 4 | 2006 | 573 | 0.110 |
Why?
|
| Young Adult | 3 | 2020 | 2581 | 0.110 |
Why?
|
| Desulfovibrio vulgaris | 2 | 2004 | 17 | 0.110 |
Why?
|
| Erythrocyte Membrane | 1 | 1993 | 22 | 0.110 |
Why?
|
| Enzyme Inhibitors | 2 | 2008 | 247 | 0.110 |
Why?
|
| Antibodies | 2 | 2011 | 124 | 0.110 |
Why?
|
| Hemolysin Proteins | 1 | 1993 | 53 | 0.110 |
Why?
|
| Co-Repressor Proteins | 1 | 2013 | 8 | 0.110 |
Why?
|
| Bucladesine | 1 | 2013 | 11 | 0.110 |
Why?
|
| Transcription Factor HES-1 | 1 | 2013 | 6 | 0.110 |
Why?
|
| Luciferases | 1 | 2013 | 49 | 0.110 |
Why?
|
| Fluorescent Dyes | 2 | 2006 | 88 | 0.110 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 1259 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 46 | 0.110 |
Why?
|
| Immunoblotting | 1 | 2013 | 122 | 0.100 |
Why?
|
| Homeodomain Proteins | 1 | 2013 | 74 | 0.100 |
Why?
|
| MAP Kinase Signaling System | 2 | 2003 | 93 | 0.100 |
Why?
|
| HEK293 Cells | 1 | 2013 | 172 | 0.100 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2012 | 14 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2003 | 228 | 0.100 |
Why?
|
| Sepsis | 1 | 2013 | 81 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2009 | 129 | 0.100 |
Why?
|
| Phytic Acid | 1 | 2012 | 4 | 0.100 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 152 | 0.100 |
Why?
|
| Serum Amyloid A Protein | 1 | 2011 | 2 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 3 | 2021 | 316 | 0.100 |
Why?
|
| Chlorides | 1 | 2011 | 13 | 0.100 |
Why?
|
| Sulfur Compounds | 1 | 2011 | 3 | 0.100 |
Why?
|
| Colony Count, Microbial | 2 | 2008 | 78 | 0.100 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2011 | 5 | 0.100 |
Why?
|
| Osmolar Concentration | 1 | 2011 | 25 | 0.100 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 42 | 0.100 |
Why?
|
| Protein Transport | 1 | 2012 | 152 | 0.100 |
Why?
|
| DNA Transposable Elements | 2 | 2008 | 32 | 0.090 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 400 | 0.090 |
Why?
|
| Genes, Reporter | 1 | 2011 | 87 | 0.090 |
Why?
|
| Chemokines | 1 | 2011 | 73 | 0.090 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 36 | 0.090 |
Why?
|
| Threonine | 1 | 2011 | 21 | 0.090 |
Why?
|
| Mutant Proteins | 1 | 2011 | 25 | 0.090 |
Why?
|
| Male | 9 | 2021 | 12870 | 0.090 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2009 | 75 | 0.090 |
Why?
|
| Serine | 1 | 2011 | 48 | 0.090 |
Why?
|
| Interferon-gamma | 1 | 2011 | 102 | 0.090 |
Why?
|
| Gene Silencing | 1 | 2011 | 63 | 0.090 |
Why?
|
| Cell Survival | 2 | 2011 | 394 | 0.090 |
Why?
|
| Stereoisomerism | 2 | 2007 | 45 | 0.090 |
Why?
|
| DNA Mutational Analysis | 1 | 2011 | 90 | 0.090 |
Why?
|
| Mutation, Missense | 1 | 2011 | 67 | 0.090 |
Why?
|
| Cell Separation | 1 | 2010 | 55 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 100 | 0.090 |
Why?
|
| Mice, Knockout | 4 | 2011 | 783 | 0.090 |
Why?
|
| Antibody Formation | 3 | 2024 | 75 | 0.090 |
Why?
|
| Myelin Basic Protein | 1 | 2009 | 4 | 0.090 |
Why?
|
| Phosphopeptides | 1 | 2009 | 11 | 0.090 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 113 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 330 | 0.080 |
Why?
|
| Lysosomes | 1 | 2010 | 54 | 0.080 |
Why?
|
| Macrophages, Alveolar | 1 | 2009 | 35 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 165 | 0.080 |
Why?
|
| Gene Order | 1 | 2008 | 9 | 0.080 |
Why?
|
| Nisin | 1 | 2008 | 2 | 0.080 |
Why?
|
| Incidence | 1 | 2010 | 545 | 0.080 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 186 | 0.080 |
Why?
|
| Cell Death | 2 | 2011 | 110 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 110 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2008 | 32 | 0.080 |
Why?
|
| Copper | 2 | 2004 | 44 | 0.080 |
Why?
|
| Microscopy, Confocal | 1 | 2008 | 110 | 0.080 |
Why?
|
| beta Catenin | 1 | 2008 | 62 | 0.080 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 273 | 0.080 |
Why?
|
| Dimerization | 2 | 2007 | 75 | 0.080 |
Why?
|
| Alanine Racemase | 1 | 2007 | 2 | 0.070 |
Why?
|
| Glucosyltransferases | 1 | 2007 | 3 | 0.070 |
Why?
|
| Mice, Inbred DBA | 1 | 2007 | 30 | 0.070 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2007 | 11 | 0.070 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2007 | 22 | 0.070 |
Why?
|
| bcl-X Protein | 1 | 2007 | 34 | 0.070 |
Why?
|
| Amino Acid Isomerases | 1 | 2007 | 1 | 0.070 |
Why?
|
| Mitochondrial Proteins | 1 | 2007 | 72 | 0.070 |
Why?
|
| Genes, MDR | 1 | 2006 | 5 | 0.070 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2006 | 23 | 0.070 |
Why?
|
| Protein Structure, Quaternary | 1 | 2006 | 26 | 0.070 |
Why?
|
| Transduction, Genetic | 1 | 2006 | 24 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 147 | 0.070 |
Why?
|
| Lethal Dose 50 | 1 | 2006 | 13 | 0.070 |
Why?
|
| NIH 3T3 Cells | 1 | 2006 | 44 | 0.070 |
Why?
|
| Myocytes, Cardiac | 1 | 2006 | 59 | 0.070 |
Why?
|
| Endosomes | 1 | 2006 | 44 | 0.070 |
Why?
|
| Myocardium | 1 | 2007 | 171 | 0.070 |
Why?
|
| Species Specificity | 1 | 2006 | 186 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2011 | 253 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 2 | 2003 | 262 | 0.060 |
Why?
|
| Air Sacs | 1 | 2005 | 2 | 0.060 |
Why?
|
| Rats | 2 | 2006 | 1545 | 0.060 |
Why?
|
| Swiss 3T3 Cells | 1 | 2005 | 2 | 0.060 |
Why?
|
| Skull | 1 | 2005 | 36 | 0.060 |
Why?
|
| Necrosis | 1 | 2005 | 81 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 190 | 0.060 |
Why?
|
| Gastrointestinal Tract | 1 | 2005 | 34 | 0.060 |
Why?
|
| Genotype | 1 | 2006 | 442 | 0.060 |
Why?
|
| Cholesterol | 1 | 2006 | 182 | 0.060 |
Why?
|
| Heart Rate | 1 | 2006 | 374 | 0.060 |
Why?
|
| Ecosystem | 1 | 2006 | 205 | 0.060 |
Why?
|
| Chemokine CXCL12 | 1 | 2024 | 9 | 0.060 |
Why?
|
| Endopeptidases | 1 | 2004 | 20 | 0.060 |
Why?
|
| Glycosyltransferases | 1 | 2004 | 31 | 0.060 |
Why?
|
| Mercury | 1 | 2004 | 12 | 0.060 |
Why?
|
| Isoenzymes | 2 | 2018 | 86 | 0.060 |
Why?
|
| Cysteine Endopeptidases | 1 | 2003 | 17 | 0.060 |
Why?
|
| Multienzyme Complexes | 1 | 2003 | 29 | 0.060 |
Why?
|
| Ubiquitin | 1 | 2003 | 24 | 0.060 |
Why?
|
| Molecular Motor Proteins | 1 | 2003 | 12 | 0.060 |
Why?
|
| Tubulin | 1 | 2003 | 30 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2003 | 42 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2003 | 80 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2003 | 155 | 0.050 |
Why?
|
| Liver | 1 | 2005 | 415 | 0.050 |
Why?
|
| Vimentin | 1 | 2002 | 26 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2002 | 56 | 0.050 |
Why?
|
| Lactates | 1 | 2002 | 18 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2015 | 276 | 0.050 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2022 | 13 | 0.050 |
Why?
|
| Desulfovibrio | 1 | 2002 | 20 | 0.050 |
Why?
|
| Bortezomib | 1 | 2021 | 18 | 0.050 |
Why?
|
| Immunophenotyping | 1 | 2022 | 58 | 0.050 |
Why?
|
| Hydrogen | 1 | 2002 | 56 | 0.050 |
Why?
|
| Gene Editing | 1 | 2021 | 19 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2022 | 82 | 0.050 |
Why?
|
| Sulfates | 1 | 2002 | 86 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2021 | 117 | 0.050 |
Why?
|
| Ligands | 1 | 2022 | 168 | 0.050 |
Why?
|
| Immunity | 1 | 2021 | 26 | 0.050 |
Why?
|
| GTP Phosphohydrolases | 1 | 2001 | 18 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2001 | 149 | 0.040 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2020 | 15 | 0.040 |
Why?
|
| Naphthalenesulfonates | 1 | 2000 | 1 | 0.040 |
Why?
|
| Proton-Translocating ATPases | 1 | 2000 | 7 | 0.040 |
Why?
|
| Turkey | 1 | 2020 | 9 | 0.040 |
Why?
|
| Serine Endopeptidases | 1 | 2000 | 18 | 0.040 |
Why?
|
| Tryptophan | 1 | 2000 | 39 | 0.040 |
Why?
|
| Mucous Membrane | 1 | 2020 | 26 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2020 | 22 | 0.040 |
Why?
|
| Universities | 1 | 2020 | 115 | 0.040 |
Why?
|
| Public Health | 1 | 2020 | 84 | 0.040 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 1999 | 6 | 0.040 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1999 | 26 | 0.040 |
Why?
|
| Antigens, Viral | 1 | 1999 | 23 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 233 | 0.040 |
Why?
|
| CD4 Antigens | 1 | 1998 | 18 | 0.040 |
Why?
|
| H-2 Antigens | 1 | 1998 | 14 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 2 | 2003 | 364 | 0.040 |
Why?
|
| Antigens | 1 | 2019 | 66 | 0.040 |
Why?
|
| Escherichia coli | 2 | 2007 | 329 | 0.040 |
Why?
|
| Disulfides | 1 | 1998 | 33 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 700 | 0.040 |
Why?
|
| Biomarkers | 1 | 2022 | 733 | 0.040 |
Why?
|
| Cysteine | 1 | 1998 | 67 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 105 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 1998 | 130 | 0.040 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1998 | 15 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1998 | 100 | 0.040 |
Why?
|
| Inflammation | 1 | 2022 | 601 | 0.040 |
Why?
|
| Culture Media | 2 | 2008 | 97 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2008 | 135 | 0.040 |
Why?
|
| Proteomics | 1 | 2018 | 177 | 0.030 |
Why?
|
| Cross-Priming | 1 | 2016 | 5 | 0.030 |
Why?
|
| Haptens | 1 | 2016 | 8 | 0.030 |
Why?
|
| Listeria monocytogenes | 1 | 1996 | 58 | 0.030 |
Why?
|
| Proteins | 1 | 1998 | 244 | 0.030 |
Why?
|
| Hemolysis | 2 | 1994 | 46 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 1 | 2015 | 20 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 2015 | 25 | 0.030 |
Why?
|
| Interleukins | 1 | 2016 | 108 | 0.030 |
Why?
|
| Troponin I | 1 | 2015 | 14 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 1927 | 0.030 |
Why?
|
| Aeromonas hydrophila | 1 | 1995 | 2 | 0.030 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 1995 | 13 | 0.030 |
Why?
|
| Type C Phospholipases | 1 | 1994 | 31 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1995 | 205 | 0.030 |
Why?
|
| United States | 1 | 2020 | 2033 | 0.030 |
Why?
|
| Models, Biological | 1 | 1996 | 446 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2007 | 441 | 0.030 |
Why?
|
| Trypsin | 1 | 1993 | 24 | 0.030 |
Why?
|
| Potassium | 1 | 1993 | 41 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 1993 | 42 | 0.030 |
Why?
|
| Viper Venoms | 1 | 2013 | 5 | 0.030 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2013 | 16 | 0.030 |
Why?
|
| Gram-Positive Bacteria | 1 | 2013 | 33 | 0.030 |
Why?
|
| Immune System | 1 | 2013 | 29 | 0.030 |
Why?
|
| RNA, Bacterial | 2 | 2004 | 65 | 0.030 |
Why?
|
| Aged | 2 | 2020 | 5167 | 0.030 |
Why?
|
| Mixed Function Oxygenases | 1 | 2012 | 19 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 60 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2012 | 50 | 0.030 |
Why?
|
| Actins | 1 | 2012 | 93 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 1992 | 73 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 45 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2011 | 14 | 0.020 |
Why?
|
| Protective Agents | 1 | 2011 | 17 | 0.020 |
Why?
|
| Rabbits | 1 | 1992 | 272 | 0.020 |
Why?
|
| Glycolipids | 1 | 2011 | 18 | 0.020 |
Why?
|
| Endpoint Determination | 1 | 2011 | 17 | 0.020 |
Why?
|
| Bioterrorism | 1 | 2010 | 28 | 0.020 |
Why?
|
| Blood | 1 | 2010 | 33 | 0.020 |
Why?
|
| Penicillamine | 1 | 1990 | 9 | 0.020 |
Why?
|
| Biotin | 1 | 1990 | 25 | 0.020 |
Why?
|
| Sheep | 1 | 2010 | 97 | 0.020 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2009 | 7 | 0.020 |
Why?
|
| Adjuvants, Immunologic | 1 | 2010 | 62 | 0.020 |
Why?
|
| Mice, Inbred A | 1 | 2008 | 14 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2008 | 61 | 0.020 |
Why?
|
| African Americans | 1 | 2011 | 350 | 0.020 |
Why?
|
| Succinimides | 1 | 2008 | 6 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2008 | 80 | 0.020 |
Why?
|
| Structural Homology, Protein | 1 | 2007 | 8 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 161 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 2007 | 36 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2007 | 50 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 130 | 0.020 |
Why?
|
| Chloramphenicol | 1 | 2006 | 6 | 0.020 |
Why?
|
| Oklahoma | 1 | 2010 | 973 | 0.020 |
Why?
|
| Operon | 1 | 2006 | 40 | 0.020 |
Why?
|
| Binding Sites | 1 | 2007 | 338 | 0.020 |
Why?
|
| Anaerobiosis | 1 | 2005 | 90 | 0.020 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2005 | 27 | 0.020 |
Why?
|
| Plasmids | 1 | 2005 | 122 | 0.020 |
Why?
|
| Random Amplified Polymorphic DNA Technique | 1 | 2004 | 4 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 2003 | 22 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2003 | 45 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2003 | 30 | 0.010 |
Why?
|
| RNA, Ribosomal | 1 | 2003 | 51 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2003 | 167 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 439 | 0.010 |
Why?
|
| DNA Primers | 1 | 2003 | 143 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2002 | 46 | 0.010 |
Why?
|
| Sulfides | 1 | 2002 | 38 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2002 | 354 | 0.010 |
Why?
|
| Virus Diseases | 1 | 1999 | 38 | 0.010 |
Why?
|
| Antigen Presentation | 1 | 1999 | 78 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 1999 | 104 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1998 | 58 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1998 | 61 | 0.010 |
Why?
|
| Immunotherapy | 1 | 1999 | 134 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 1998 | 163 | 0.010 |
Why?
|
| Gas Gangrene | 1 | 1994 | 3 | 0.010 |
Why?
|
| Immunocompetence | 1 | 1994 | 6 | 0.010 |
Why?
|
| Aziridines | 1 | 1990 | 2 | 0.010 |
Why?
|
| Serum Albumin, Bovine | 1 | 1990 | 22 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 1990 | 42 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1990 | 35 | 0.010 |
Why?
|
| Drug Carriers | 1 | 1990 | 109 | 0.000 |
Why?
|
| Kinetics | 1 | 1990 | 538 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1990 | 802 | 0.000 |
Why?
|